Table 1.
Control group (n = 10) | Cancer group (n = 6) | P value | |
---|---|---|---|
Age | 51.6(45–57) | 57.3(46–75) | 0.29 |
Menopausal status | 0.12 | ||
Pre/Peri | 8 | 2 | |
Post | 2 | 4 | |
Parity | 5.1(1–13) | 3.1(2–5) | 0.17 |
History of hypertension | 0.52 | ||
Yes | 1 | 2 | |
NO | 9 | 4 | |
History of diabetes | 0.70 | ||
Yes | 1 | 1 | |
NO | 9 | 5 | |
Stage (%) | |||
II | 2(33.3) | ||
III | 4(66.7) | ||
Histotype (%) | |||
Uterine myoma | 3(30) | – | |
Uterine adenomyosis | 7(70) | – | |
Ovarian serous carcinoma | – | 6(100) |
The P-value of age and parity were assessed by Student’s t-test. The P-value of menopausal status, history of hypertension and diabetes were calculated by the chi-square test